← Back to Search

Stem Cell Transplantation

Haplo SCT for Acute Myeloid Leukemia

N/A

Waitlist Available

Research Sponsored by Jonas Mattsson

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years and 5 years

Awards & highlights

Study Summary

This trial is ongoing, but not yet recruiting patients.

Eligible Conditions

Acute Myeloid Leukemia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years and 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years and 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Intention to treat analysis of 2-year graft-vs.-host disease- and relapse-free survival

Secondary outcome measures

Acute graft.vs.-host disease

Bone Transplantation

Engraftment of neutrophil granulocytes

+12 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Haplo SCTExperimental Treatment1 Intervention

Allogeneic stem cell transplantation with a haplo-identical family donor graft.

Group II: URD SCTActive Control1 Intervention

Allogeneic stem cell transplantation with a matched unrelated donor graft.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Jonas MattssonLead Sponsor

Helsinki University Central HospitalOTHER

429 Previous Clinical Trials

579,028 Total Patients Enrolled

Sahlgrenska University Hospital, SwedenOTHER

415 Previous Clinical Trials

297,583 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings still available for participants in the clinical trial?

"Clinicaltrials.gov provides evidence that recruitment for this medical experiment is still underway, with the first posting on 11th December 2019 and most recent edits made in March 2020."

Answered by AI

What is the aggregate tally of participants in this medical experiment?

"Yes, the information posted on clinicaltrials.gov demonstrates that this medical research is actively recruiting patients. This investigation was originally advertised on November 12th 2019 and has been updated for the last time on February 3rd 2020. 200 individuals need to be enrolled from a single center."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Randomized Clinical Study Assessing Haplo vs. URD in AML

Jonas Mattsson 2019. "Randomized Clinical Study Assessing Haplo vs. URD in AML". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04067180.